Počet záznamov: 1
Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (doxetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancer
- Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (doxetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancer / W. P. Li ... [et al.]. Neoplasma Vol. 67, no. 6 (2020), s. 1409-1415
článok
Počet záznamov: 1